The prospects of cariprazine in the treatment of schizophrenia

被引：6
|
作者：
Scarff, Jonathan R. [1 ]
机构：
[1] Dept Vet Affairs, Community Based Outpatient Clin, 279 North Grove Med Pk Dr, Spartanburg, SC 29303 USA
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 11期
关键词：
RECEPTOR PARTIAL AGONIST; NEGATIVE SYMPTOMS; MODEL;
D O I：
10.1177/2045125317727260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [41] Efficacy of cariprazine in the treatment of acute and primary negative symptoms of schizophrenia: Posthoc analyses versus risperidone
    Sebe, B.
    Barabassy, A.
    Balogh, A.
    Acsai, K.
    Laszlovszky, I.
    Szatmari, B.
    Harsanyi, J.
    Patel, M.
    Earley, W.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S23 - S23
  • [42] Safety and tolerability of cariprazine in long-term treatment of schizophrenia: Integrated summary of safety data
    Durgam, S.
    Nasrallah, H. A.
    Nasrallah, Henry A.
    Cutler, A.
    Wang, Y.
    Lu, K.
    Nagy, K.
    Laszlovszky, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 68 - 68
  • [43] The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
    Henry A. Nasrallah
    Willie Earley
    Andrew J. Cutler
    Yao Wang
    Kaifeng Lu
    István Laszlovszky
    György Németh
    Suresh Durgam
    BMC Psychiatry, 17
  • [44] Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
    Citrome, Leslie
    ADVANCES IN THERAPY, 2013, 30 (02) : 114 - 126
  • [45] Cardiac safety with cariprazine treatment
    Barabassy, A.
    Sebe, B.
    Laszlovszky, I.
    Szatmari, B.
    Balogh, A.
    Acsai, K.
    Patel, M.
    Earley, W.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S252 - S253
  • [46] Case series: Cariprazine in early-onset schizophrenia
    Ivanova, Elena
    Maslinkova, Desislava
    Polnareva, Nadia
    Milanova, Vihra
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [47] EFFICACY OF CARIPRAZINE IN PATIENTS WITH SCHIZOPHRENIA BASED ON STAGE OF ILLNESS
    Mofsen, Ricky
    Cheng, Cheng-Tao
    Nemeth, Gyorgy
    Barabassy, Agota
    Earley, Willie
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S55 - S55
  • [48] RELATIONSHIP BETWEEN TIMING OF RELAPSE AND PLASMA DRUG LEVELS FOLLOWING DISCONTINUATION OF CARIPRAZINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA
    Correll, Christoph U.
    Jain, Rakesh
    Meyer, Jonathan
    Periclou, Antonia
    Carrothers, Timothy
    Barabassy, Agota
    Patel, Mehul
    Earley, Willie
    Kershenstine, Mindy
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S317 - S317
  • [49] Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
    Nakamura, Tadakatsu
    Kubota, Tomoko
    Iwakaji, Atsushi
    Imada, Masayoshi
    Kapas, Margit
    Morio, Yasunori
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 327 - 338
  • [50] Categorical improvements in disease severity in schizophrenia patients treated with cariprazine
    Volk, S.
    Zukin, S.
    Lu, K.
    Debelle, M.
    Laszlovszky, I.
    Durgam, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S532 - S532
12345